Skip to main content
Publications
Fernandez-Barres S, Romaguera D, Valvi D, Martinez D Mediterranean dietary pattern in pregnant women and offspring risk of overweight and abdominal obesity in early childhood: the INMA birth cohort study 10.1111/ijpo.12092
Anthony L, Horsch D, Ervin C DiBenedetti D Assessing treatment benefit of telotristat etiprate in patients with carcinoid syndrome: patient exit interviews 10.1530/endoabs.46.P11
Abdul-Jawad Altisent O, Durand E, Munoz-Garcia AJ, Nombela-Franco L, Cheema A, Kefer J, Gutierrez E, Benitez LM, Amat-Santos IJ, Serra V, Eltchaninoff H, Alnasser SM, Elizaga J, Dager A, Garcia Del Blanco B, Ortas-Nadal MDR, Marsal JR Reply: antithrombotic regimen in post-TAVR atrial fibrillation: not an easy decision 10.1016/j.jcin.2016.09.038
Strober B, Blauvelt A, Zhao Y, Milutinovic M, Mollon P, You R, Sherif B Secukinumab provides better relief from psoriasis-related pain, itching, and scaling than ustekinumab
Tyring S, Sofen H, Fretzin S, Rich P, Zhao Y, Herrera V, Sherif B Secukinumab provides better relief from quality-of-life impact than etanercept in moderate to severe psoriasis
Sofen H, Korman N, Rich P, Fretzin S, Zhao Y, Herrera V, Sherif B McLeod L Secukinumab provides better relief from quality-of-life impact than placebo in moderate to severe psoriasis
Blauvelt A, Korman N, Mollon P, Zhao Y, Milutinovic M, You R, Sherif B Secukinumab provides faster and better quality of life impact than ustekinumab in psoriasis
Tyring S, Sofen H, Fretzin S, Rich P, Zhao Y, Herrera V, Sherif B Secukinumab provides more effective relief from skin-related quality-of-life impact than etanercept in moderate to severe psoriasis
Sofen H, Korman N, Rich P, Fretzin S, Zhao Y, Herrera V, Sherif B McLeod L Secukinumab provides more effective relief from skin-related quality-of-life impact than placebo in moderate to severe psoriasis
Sauchelli S Interaction between orexin-A and sleep quality in females in extreme weight conditions 10.1002/erv.2484
Tyring S, Sofen H, Fretzin S, Rich P, Zhao Y, Herrera V, Sherif B Secukinumab provides more effective relief from skin-related quality-of-life impact than etanercept in moderate to severe psoriasis
Sofen H, Korman N, Rich P, Fretzin S, Zhao Y, Herrera V, Sherif B McLeod L Secukinumab provides more effective relief from skin-related quality-of-life impact than placebo in moderate to severe psoriasis
Strober B, Blauvelt A, Zhao Y, Milutinovic M, Mollon P, You R, Sherif B Secukinumab treatment provides more effective relief from patient-reported psoriasis-related pain, itching, and scaling than ustekinumab
Blauvelt A, Korman N, Mollon P, Zhou Y, Milutinovic M, You R, Sherif B Secukinumab treatment provides faster and more effective relief from patient-reported quality of life impact than ustekinumab in subjects with moderate to severe plaque psoriasis
Police RL, Trask PC, Wang J, Olivares R, Khan S Colosia A Njue A Randomized controlled trials in relapsed/refractory follicular lymphoma: a systematic review and meta-analysis 10.1177/1078155215603230
Tyring S, Sofen H, Fretzin S, Rich P, Zhao Y, Herrera V, Sherif B Secukinumab provides more effective relief from skin-related quality-of-life impact than etanercept in moderate to severe psoriasis
Sofen H, Korman N, Rich P, Fretzin S, Zhao Y, Herrera V, Sherif B McLeod L Secukinumab provides more effective relief from skin-related quality-of-life impact than placebo in moderate to severe psoriasis
Strober B, Jazayeri S, Thaci D, Augustin M, Zhou Y, Gilloteau I, McLeod LD Sherif B Secukinumab provides faster and more sustained 52-week complete relief from psoriasis-related pain, itching, and scaling than ustekinumab in subjects with moderate-to-severe plaque psoriasis
Vender R, Leonardi C, Puig L, Ziv M, Zhou Y, Gilloteau I, Sherif B McLeod LD Secukinumab provides greater cumulative 52-week skin clearance and quality of life benefit in patients with moderate-to-severe plaque psoriasis than ustekinumab: an area under the curve analysis
Blauvelt A, Mehlis S, Vanaclocha F, Vender R, Zhao Y, Gilloteau I, Davenport E Secukinumab provides greater 52-week sustained relief from dermatology-related quality of life impact on clothing choice and sexual function than ustekinumab
Stempel DA, Szefler SJ, Pedersen S, Zeiger RS, Yeakey AM, Lee LA, Liu AH, Mitchell H, Kral KM, Raphiou IH, Prillaman BA Safety of adding salmeterol to fluticasone propionate in children with asthma 10.1056/NEJMoa1606356
Afonso A, Schmiedl S, Becker C, Tcherny-Lessenot S, Primatesta P, Plana E A methodological comparison of two European primary care databases and replication in a US claims database: inhaled long-acting beta-2-agonists and the risk of acute myocardial infarction
Abdul-Jawad Altisent O, Durand E, Munoz-Garcia AJ, Nombela-Franco L, Cheema A, Kefer J, Gutierrez E, Benitez LM, Amat-Santos IJ, Serra V, Eltchaninoff H, Alnasser SM, Elizaga J, Dager A, Garcia Del Blanco B, Ortas-Nadal Mdel R, Marsal JR Warfarin and antiplatelet therapy versus Warfarin alone for treating patients with atrial fibrillation undergoing transcatheter aortic valve replacement 10.1016/j.jcin.2016.06.025
O'Connor G, Pinero Casas M, Basagana X, Vicente ML, Davand P, Torrent M, Martinez-Murciano D Garcia-Esteban R Television viewing duration during childhood and long-association with adolescent neuropsychological outcomes 10.1016/j.pmedr.2016.08.013
Blitstein JL, Cates SC, Hersey J, Montgomery D, Shelley M, Hradek C, Kosa K Adding a social marketing campaign to a school-based nutrition education program improves children's dietary intake: a quasi-experimental study 10.1016/j.jand.2015.12.016.
Fagundo AB, Jimenez-Murcia S, Giner-Bartolome C, Aguera Z, Sauchelli S Modulation of irisin and physical activity on executive functions in obesity and morbid obesity 10.1038/srep30820
